Extract notice to the Minister
Epysqli (Hémoglobinurie paroxystique nocturne)
Common name / Subject : éculizumab
Name of the manufacturer : Accelera / Samsung Bioepis Co., Ltd.
Form : Sol. Perf. I.V. (fiole)
Dosage : 10 mg/mL (30 mL)
Name of the manufacturer : Accelera / Samsung Bioepis Co., Ltd.
Form : Sol. Perf. I.V. (fiole)
Dosage : 10 mg/mL (30 mL)
Indication : Médicament biosimilaire - Hémoglobinurie paroxystique nocturne
INESSS' Recommendation
Inscription – Sous conditions
Minister's decisions
Surseoir à la décision (2026-10-22)
Evaluation published on October 20, 2026
INESSSid: 30773
Recevable on July 06, 2026